- Zomedica (ZOM) shares have suffered since the sale of its first Truforma product.
- ZOM shares closed up 2% on Friday.
- ZOM shares still up significantly in 2021 as retail investors back it.
Update March 22: Shares in ZOM continue to fall post the first sale of its Truforma diagnostic product. ZOM shares are down over 4% in Monday's pre-market session. ZOM shares had recovered slightly on Friday in line with the broader market.
Update: ZOM shares continue to suffer from post-Truforma sale as investors likely move on to the next meme name, or back to the king, in Gamestop. ZOM does have a solid investment case but not at this level with a $1.99 market capitalization in a market that in its entirety is worth just over $2 billion for diagnostic pet products. Maybe investors have realized they have pushed the valuation too far or maybe they have moved into the next meme stock but either way ZOM shares have been struggling, despite the positive news, which is never a good sign.
NYSEAMERICAN: ZOM had investors believing that the upcoming sales of its Truforma diagnostic platform would justify the 1,300% growth over the past year. Well, so far they were unfortunately wrong. On Thursday, Zomedica continued its downward slide as the stock dropped by 6.67% to close the trading session at $2.10. Shares have now fallen nearly 20% since the start of the week, and it could just be bad timing for Zomedica as the recent market correction has hit growth stocks especially hard.
Stay up to speed with hot stocks' news!
To start the week, Zomedica did announce its first official sale of Truforma to an animal care center in New York. It was the moment that investors had been waiting for since the diagnostics platform for cats and dogs has been in development over the past few years. Surprisingly, the sales were met with a steep drop off in the stock’s price, a sign that shareholders are wising up to the high valuation. Truforma first reached mainstream appeal when Carole Baskin of the Tiger King fame, mentioned the platform in a paid video on YouTube. Since then, Zomedica has graduated to a full on Reddit meme stock which helped to propel its stock to its current price levels.
ZOM Stock forecast
Investors are quickly figuring out that Wall Street estimates of $20 million in sales by 2023 simply does not jive with an inflated $2 billion market cap that Zomedica now has. That gives Zomedica a forward looking price to sales ratio of 100, which illustrates just how overvalued Zomedica’s stock may still be.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD holds above 1.0450 after German sentiment data
EUR/USD stays in positive territory above 1.0450 after retracing a portion of its bullish opening gap. The data from Germany showed that the IFO - Current Assessment Index declined to 84.3 in November from 85.7, while the Expectations Index edged lower to 87.2 from 87.3.
GBP/USD pulls back toward 1.2550 as US Dollar sell-off pauses
GBP/USD is falling back toward 1.2550 in the European session on Monday after opening with a bullish gap at the start of a new week. A pause in the US Dollar decline alongside the US Treasury bond yields weighs down on the pair. Speeches from BoE policymakers are eyed.
Gold price manages to hold above $2,650 amid sliding US bond yields
Gold price maintains its heavily offered tone through the early European session on Monday, albeit manages to hold above the $2,650 level and defend the 100-period Simple Moving Average (SMA) on the 4-hour chart. Scott Bessent's nomination as US Treasury Secretary clears a major point of uncertainty for markets.
Bitcoin consolidates after a new all-time high of $99,500
Bitcoin remains strong above $97,700 after reaching a record high of $99,588. At the same time, Ethereum edges closer to breaking its weekly resistance, signaling potential gains. Ripple holds steady at a critical support level, hinting at continued upward momentum.
Eurozone PMI sounds the alarm about growth once more
The composite PMI dropped from 50 to 48.1, once more stressing growth concerns for the eurozone. Hard data has actually come in better than expected recently – so ahead of the December meeting, the ECB has to figure out whether this is the PMI crying wolf or whether it should take this signal seriously. We think it’s the latter.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.